{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06312657",
            "orgStudyIdInfo": {
                "id": "81971"
            },
            "secondaryIdInfos": [
                {
                    "id": "R01DA047368",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01DA047368"
                }
            ],
            "organization": {
                "fullName": "University of Kentucky",
                "class": "OTHER"
            },
            "briefTitle": "Behavioral Effects of Drugs Inpatient 44 Neurobehavioral Mechanisms of Opioid Choice",
            "officialTitle": "Behavioral Effects of Drugs Inpatient 44: Neurobehavioral Mechanisms of Opioid Choice",
            "acronym": "BED(In)(44)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "behavioral-effects-of-drugs-inpatient-neurobehavioral-mechanisms-of-opioid-choice"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-16",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-03-28",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-03-28",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-08",
            "studyFirstSubmitQcDate": "2024-03-08",
            "studyFirstPostDateStruct": {
                "date": "2024-03-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Joshua A. Lile, Ph.D.",
                "investigatorTitle": "Professor",
                "investigatorAffiliation": "University of Kentucky"
            },
            "leadSponsor": {
                "name": "Joshua A. Lile, Ph.D.",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Drug Abuse (NIDA)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The objective of this protocol is to use probabilistic choice tasks, reinforcement learning modeling and fMRI to determine the neurobehavioral mechanisms of decision-making in individuals with opioid use disorder and physical opioid dependence."
        },
        "conditionsModule": {
            "conditions": [
                "Opioid Use Disorder"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 18,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Money-vs-money task",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Behavioral: Drug Cue"
                    ]
                },
                {
                    "label": "Drug-vs-money task",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Behavioral: Money",
                        "Drug: Withdrawal"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Drug Cue",
                    "description": "Individualized drug cues paired with choice options reinforced by $0.25",
                    "armGroupLabels": [
                        "Money-vs-money task"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Money",
                    "description": "Two money values will be tested ($0.25 and $4.00)",
                    "armGroupLabels": [
                        "Drug-vs-money task"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Withdrawal",
                    "description": "Participants will be maintained on an opioid agonist. Placebo will be substituted to produce mild-to-moderate withdrawal.",
                    "armGroupLabels": [
                        "Drug-vs-money task"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Task choices",
                    "description": "Number of choices of each option selected.",
                    "timeFrame": "Tasks will take approximately 45-60 minutes to complete. Participants will complete 5 sessions in which a choice task will be administered."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Individuals must meet criteria for moderate/severe opioid use disorder, report past month opioid misuse, and be physically dependent on short-acting opioids (e.g., heroin, hydromorphone, fentanyl), as evidenced by either urine sample positive for recent opioid use during each visit or if opioid negative, displaying frank withdrawal during screening.\n* History of intravenous opioid use.\n* Baseline O2 saturation of 95% or greater.\n* Between the ages of 18-50 years.\n* Female subjects must be using an effective form of birth control (e.g., birth control pills, surgical sterilization, IUD, cervical cap with a spermicide, or abstinence). Urine pregnancy tests will be conducted prior to sessions to ensure that female subjects do not participate if pregnant.\n* Able to speak and read English.\n* Otherwise healthy.\n\nExclusion Criteria:\n\n* History of, or current, clinically significant physical disease (e.g., respiratory disease \\[asthma, COPD, sleep apnea\\], impaired cardiovascular functioning, seizure disorder or CNS tumors) or current or past history of psychiatric disorder that would limit compliance in the studies, other than substance use disorder.\n* Meet diagnostic criteria for psychoactive substance use disorder for substances other than opioids (OUD subjects only) or nicotine/caffeine that would require detoxification (i.e., alcohol, benzodiazepines or barbiturates). Negative urine/breath samples for these substances, and the absence of withdrawal, will be required during screening.\n* Contraindications for MRI scanning (e.g., pacemaker, metal implants, claustrophobia, or any other implanted medical device).\n* Vision or hearing problems that would preclude completion of experimental tasks.\n* Poor venous access.\n* Regular use of other medications, with the exception of hormone-based contraceptives for female subjects, daily multivitamins or short-term antibiotic prescriptions.\n* At risk for respiratory complications and have predictors of difficult bag mask ventilation (e.g., dentures, very full beard), in case emergency respiratory intervention is needed.\n* Seeking treatment for SUD or currently taking buprenorphine or methadone as the primary opioid of use.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "50 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Joshua Lile, Ph.D.",
                    "role": "CONTACT",
                    "phone": "8593236034",
                    "email": "jalile2@uky.edu"
                }
            ],
            "locations": [
                {
                    "facility": "University of Kentucky",
                    "status": "RECRUITING",
                    "city": "Lexington",
                    "state": "Kentucky",
                    "zip": "40506",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joshua Lile, PhD",
                            "role": "CONTACT",
                            "email": "jalile2@uky.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.98869,
                        "lon": -84.47772
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009293",
                    "term": "Opioid-Related Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000079524",
                    "term": "Narcotic-Related Disorders"
                },
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12244",
                    "name": "Opioid-Related Disorders",
                    "asFound": "Opioid Use Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2057",
                    "name": "Narcotic-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}